Medicines360 Drug Patent Portfolio

Medicines360 owns 1 orange book drug protected by 4 US patents Given below is the list of Medicines360's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11571328 IUD insertion devices 07 Sep, 2040
Active
US10028858 Intrauterine systems, IUD insertion devices, and related methods and kits therefor 22 Mar, 2034
Active
US11090186 Methods for using intrauterine systems and IUD insertion devices 24 Oct, 2033
Active
US12004992 Kits for intrauterine systems and IUD insertion devices 06 Oct, 2033
Active


Given below is the list of recent legal activities going on the following drug patents of Medicines360.

Activity Date Patent Number
Patent litigations
Recordation of Patent Grant Mailed 07 Feb, 2023 US11571328
Patent Issue Date Used in PTA Calculation 07 Feb, 2023 US11571328
Email Notification 19 Jan, 2023 US11571328
Issue Notification Mailed 18 Jan, 2023 US11571328
Mailing Corrected Notice of Allowability 06 Jan, 2023 US11571328
Email Notification 06 Jan, 2023 US11571328
Corrected Notice of Allowability 28 Dec, 2022 US11571328
Pubs Case Remand to TC 05 Dec, 2022 US11571328
Mailing Corrected Notice of Allowability 02 Dec, 2022 US11571328
Email Notification 02 Dec, 2022 US11571328
Corrected Notice of Allowability 29 Nov, 2022 US11571328
Pubs Case Remand to TC 04 Nov, 2022 US11571328
Information Disclosure Statement considered 03 Nov, 2022 US11571328
Application Is Considered Ready for Issue 03 Nov, 2022 US11571328
Dispatch to FDC 03 Nov, 2022 US11571328


Medicines360 Drug Patents' Oppositions Filed in EPO

Medicines360 drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jun 11, 2019, by Bayer Intellectual Property Gmbh / Bayer Oy / Bayerag. This opposition was filed on patent number EP12811921A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP12811921A Jun, 2019 Bayer Intellectual Property GmbH / Bayer Oy / BayerAG Patent maintained as amended


Medicines360's Family Patents

Medicines360 drugs have patent protection in a total of 19 countries. It's US patent count contributes only to 26.3% of its total global patent coverage. 4 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Medicines360 Drug List

Given below is the complete list of Medicines360's drugs and the patents protecting them.


1. Liletta

Liletta is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11571328 IUD insertion devices 07 Sep, 2040
(15 years from now)
Active
US10028858 Intrauterine systems, IUD insertion devices, and related methods and kits therefor 22 Mar, 2034
(9 years from now)
Active
US11090186 Methods for using intrauterine systems and IUD insertion devices 24 Oct, 2033
(9 years from now)
Active
US12004992 Kits for intrauterine systems and IUD insertion devices 06 Oct, 2033
(8 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Liletta's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List